Table 3.

Evolution of clinical variables over 2 yr

At TransplantationAt 6 MoAt 12 MoAt 24 Mo
Serum creatininea (μmol/L)139 (120–158)121 (114–127)121 (114–129)120 (112–127)
Creatinine clearancea (ml/min per 1.73 m2)57.6 (53.4–62.4)57.6 (54.6–61.2)60 (53–63.6)61.2 (57.6–65.4)
Total cholesterol (mmol/L)5.5 (5.3–5.8)5.9 (5.7–6.3)5.9 (5.7–6.2)5.6 (5.3–5.8)
LDL cholesterol (mmol/L)3.1 (2.8–3.4)3.6 (3.3–3.8)3.3 (3.1–3.5)3.2 (2.9–3.4)
HDL cholesterol (mmol/L)1.3 (1.2–1.4)1.6 (1.5–1.7)1.6 (1.5–1.7)1.6 (1.5–1.7)
Triglycerides (mmol/L)2.2 (1.8–2.5)1.9 (1.7–2.2)1.7 (1.5–2.0)1.6 (1.4–1.8)
HbA1c (%)8.3 (7.5–9.1), n = 247.4 (6.9–7.9), n = 617.2 (6.7–7.6), n = 656.8 (6.5–7.2), n = 66
Cyclosporin Aa (μg/L)212 (201–224), n = 82157 (119–195), n = 81109 (104–113), n = 81105 (100–109), n = 78
Body mass index (kg/m2)24 (23–24)25 (24–26)25 (24–26)25 (24–26)
Systolic BP (mmHg)144 (139–150)142 (138–146)143 (139–148)140 (136–144)
Diastolic BP (mmHg)88 (85–91)85 (83–88)86 (84–88)82 (80–85)
  • a Measured at hospital discharge at transplantation. HbA1c, glycosylated hemoglobin.